Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952;7(4):317–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol. 1966;97(6):840–53.

Article  CAS  PubMed  Google Scholar 

Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Respir Dis. 1975;111(4):497–537. https://doi.org/10.1164/arrd.1975.111.4.497.

Article  CAS  PubMed  Google Scholar 

Bosken CH, Myers JL, Greenberger PA, Katzenstein AL. Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol. 1988;12(3):216–22.

Article  CAS  PubMed  Google Scholar 

Hebisawa A, Tamura A, Kurashima A, Oobayashi C, Kawamata M, Maeda M, et al. Pathologic reconsideration on allergic bronchopulmonary aspergillosis and mycosis. Nihon Kokyuki Gakkai Zasshi. 1998;36(4):330–7. (in Japanese).

CAS  PubMed  Google Scholar 

Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977;86(4):405–14.

Article  CAS  PubMed  Google Scholar 

Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol. 1988;81(4):646–50.

Article  CAS  PubMed  Google Scholar 

Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850–73. https://doi.org/10.1111/cea.12141.

Article  CAS  PubMed  Google Scholar 

Asano K, Kamei K, Hebisawa A. Allergic bronchopulmonary mycosis - pathophysiology, histology, diagnosis, and treatment. Asia Pac Allergy. 2018;8(3):e24. https://doi.org/10.5415/apallergy.2018.8.e24.

Article  PubMed  PubMed Central  Google Scholar 

Araujo R, Rodrigues AG. Variability of germinative potential among pathogenic species of Aspergillus. J Clin Microbiol. 2004;42(9):4335–7. https://doi.org/10.1128/JCM.42.9.4335-4337.2004.

Article  PubMed  PubMed Central  Google Scholar 

Oguma T, Asano K, Tomomatsu K, Kodama M, Fukunaga K, Shiomi T, et al. Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells. J Immunol. 2011;187(2):999–1005. https://doi.org/10.4049/jimmunol.1002257.

Article  CAS  PubMed  Google Scholar 

• Muniz VS, Silva JC, Braga YAV, Melo RCN, Ueki S, Takeda M, et al. Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus. J Allergy Clin Immunol. 2018;141(2):571–585 e577. https://doi.org/10.1016/j.jaci.2017.07.048. This study demonstrates the release of extracellular traps from eosinophils in contact with A. fumigatus and in the mucus plugs of patients with ABPA.

Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest. 2018;128(3):997–1009. https://doi.org/10.1172/JCI95693.

Article  PubMed  PubMed Central  Google Scholar 

Silva JDC, Thompson-Souza GA, Barroso MV, Neves JS, Figueiredo RT. Neutrophil and eosinophil DNA extracellular trap formation: Lessons from pathogenic fungi. Front Microbiol. 2021;12:634043. https://doi.org/10.3389/fmicb.2021.634043.

Article  PubMed  PubMed Central  Google Scholar 

Ueki S, Tokunaga T, Melo RCN, Saito H, Honda K, Fukuchi M, et al. Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death. Blood. 2018;132(20):2183–7. https://doi.org/10.1182/blood-2018-04-842260.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111(5):580–8. https://doi.org/10.1177/019459989411100508.

Article  PubMed  Google Scholar 

deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol. 1995;96(1):24–35.

Article  CAS  PubMed  Google Scholar 

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82–111. https://doi.org/10.4193/Rhin20.601.

Article  CAS  PubMed  Google Scholar 

Wardlaw AJ, Rick EM, Pur Ozyigit L, Scadding A, Gaillard EA, Pashley CH. New perspectives in the diagnosis and management of allergic fungal airway disease. J Asthma Allergy. 2021;14:557–73. https://doi.org/10.2147/JAA.S251709.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Saxena P, Choudhary H, Muthu V, Sehgal IS, Dhooria S, Prasad KT, et al. Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis. J Allergy Clin Immunol Pract. 2021;9(1):328–335 e321. https://doi.org/10.1016/j.jaip.2020.08.043. This study has validated the sensitivity and specificity of the existing diagnostic criteria and proposed a modification of ISHAM criteria.

•• Asano K, Hebisawa A, Ishiguro T, Takayanagi N, Nakamura Y, Suzuki J, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2021;147(4):1261–1268 e1265. https://doi.org/10.1016/j.jaci.2020.08.029. This study has also validated the sensitivity and specificity of the existing diagnostic criteria and proposed new 10-component criteria applicable not only for ABPA but also for ABPM.

Sehgal IS, Dhooria S, Muthu V, Rudramurthy SM, Prasad KT, Chakrabarti A, et al. Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis. Mycoses. 2023;66(4):299–303. https://doi.org/10.1111/myc.13553.

Article  CAS  PubMed  Google Scholar 

Asano K, Suzuki Y, Tanaka J, Kobayashi K, Kamide Y. Treatments of refractory eosinophilic lung diseases with biologics. Allergol Int. 2023;72(1):31–40. https://doi.org/10.1016/j.alit.2022.10.004.

Article  CAS  PubMed  Google Scholar 

Agarwal R, Aggarwal AN, Dhooria S, Singh Sehgal I, Garg M, Saikia B, et al. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2016;47(2):490–8. https://doi.org/10.1183/13993003.01475-2015.

Article  CAS  PubMed  Google Scholar 

Ishiguro T, Takayanagi N, Baba Y, Takaku Y, Kagiyama N, Sugita Y. Pulmonary nontuberculous mycobacteriosis and chronic lower respiratory tract infections in patients with allergic bronchopulmonary mycosis without cystic fibrosis. Intern Med. 2016;55(9):1067–70. https://doi.org/10.2169/internalmedicine.55.5561.

Article  PubMed  Google Scholar 

Liu VX, Winthrop KL, Lu Y, Sharifi H, Nasiri HU, Ruoss SJ. Association between inhaled corticosteroid use and pulmonary nontuberculous mycobacterial infection. Ann Am Thorac Soc. 2018. https://doi.org/10.1513/AnnalsATS.201804-245OC.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki S, Asakura T, Namkoong H, Okamori S, Yagi K, Kamata H, et al. Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease: a cross-sectional study. Respir Med. 2018;138:1–6. https://doi.org/10.1016/j.rmed.2018.03.013.

Article  PubMed  Google Scholar 

Agarwal R, Dhooria S, Sehgal IS, Aggarwal AN, Garg M, Saikia B, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2018;52(3). https://doi.org/10.1183/13993003.01159-2018.

Agarwal R, Dhooria S, Singh Sehgal I, Aggarwal AN, Garg M, Saikia B, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656–64. https://doi.org/10.1016/j.chest.2018.01.005.

Article  PubMed  Google Scholar 

Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Garg M, et al. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2022;59(4). https://doi.org/10.1183/13993003.01787-2021.

Tillie-Leblond I, Germaud P, Leroyer C, Tetu L, Girard F, Devouassoux G, et al. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy. 2011;66(9):1254–6. https://doi.org/10.1111/j.1398-9995.2011.02599.x.

Article  CAS  PubMed  Google Scholar 

Aydin O, Sozener ZC, Soyyigit S, Kendirlinan R, Gencturk Z, Misirligil Z, et al. Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: one center’s experience with 14 cases. Allergy Asthma Proc. 2015;36(6):493–500. https://doi.org/10.2500/aap.2015.36.3909.

Article  PubMed  Google Scholar 

Voskamp AL, Gillman A, Symons K, Sandrini A, Rolland JM, O’Hehir RE, et al. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2015;3(2):192–9. https://doi.org/10.1016/j.jaip.2014.12.008.

Article  PubMed  Google Scholar 

Tomomatsu K, Oguma T, Baba T, Toyoshima M, Komase Y, Taniguchi M, et al. Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis complicated by chronic bacterial infection in the airways. Int Arch Allergy Immunol. 2020;181(7):499–506. https://doi.org/10.1159/000507216.

Article  CAS  PubMed  Google Scholar 

• Jin M, Douglass JA, Elborn JS, Agarwal R, Calhoun WJ, Lazarewicz S, et al. Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2023;11(3):896–905. https://doi.org/10.1016/j.jaip.2022.12.012. This study demonstrates a meta-analysis of 186 cases of ABPA with asthma or cystic fibrosis treated with omalizumab.

Article  CAS  PubMed  Google Scholar 

Schleich F, Vaia ES, Pilette C, Vandenplas O, Halloy JL, Michils A, et al. Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature. J Allergy Clin Immunol Pract. 2020. https://doi.org/10.1016/j.jaip.2020.03.023.

Article  PubMed  PubMed Central  Google Scholar 

Dhariwal J, Hearn AP, Kavanagh JE, d’Ancona G, Green L, Fernandes M, et al. Real-world effectiveness of anti-IL-5/5R therapy in severe atopic eosinophilic asthma with fungal sensitization. J Allergy Clin Immunol Pract. 2021;9(6):2315–2320 e2311. https://doi.org/10.1016/j.jaip.2021.02.048.

Article  CAS  PubMed  Google Scholar 

Caminati M, Batani V, Guidolin L, Festi G, Senna G. One-year mepolizumab for allergic bronchopulmonary aspergillosis: focus on steroid sparing effect and markers of response. Eur J Intern Med. 2022;99:112–5. https://doi.org/10.1016/j.ejim.2021.12.026.

Article  PubMed